Treatment decisions
Which hair loss treatment fits you?
The main options for women compared honestly, with the questions that decide between them: your diagnosis, your life stage and your preferences.

The short answer
For female pattern hair loss, topical minoxidil is FDA approved for women and the usual first step; the expert consensus suggests the 5% strength12. Prescription options include spironolactone and low-dose oral minoxidil. FDA-cleared laser caps are a drug-free option. All take 6 to 12 months to judge and need to continue to keep their benefit1. Pregnancy, trying to conceive and breastfeeding rule out minoxidil and the prescription pills1.
Before you choose: three deciding questions
- What is the diagnosis? These treatments are for pattern thinning. Shedding from a trigger usually settles once the cause is gone, and scarring hair loss needs a dermatologist's prescription treatment34.
- Could you become pregnant, or are you breastfeeding? Minoxidil and the prescription pills are avoided while pregnant, planning pregnancy or breastfeeding, and premenopausal women taking the prescription pills are advised to use birth control1.
- What can you stick with? Every option needs months of consistent use, so a routine you will keep beats a stronger one you will abandon.
The options side by side
| Option | Evidence | Main downsides | Who it suits |
|---|---|---|---|
| Topical minoxidil 2% or 5% | FDA approved; in a 48-week trial of 381 women, 5% beat placebo on all main measures51 | Shedding in the first 2 to 8 weeks; scalp irritation; daily routine1 | Most women with pattern loss who are not pregnant, planning or breastfeeding |
| Low-dose oral minoxidil | Off-label; a small trial found results comparable to 5% topical6 | Uncommon systemic effects such as lightheadedness, fluid retention, fast heartbeat; facial hair7 | Women who cannot manage or tolerate topical; prescribed by a doctor |
| Spironolactone | Long used for women's hair loss; 44% regrowth and 44% stable in one study of oral anti-androgens18 | Needs contraception before menopause; kidney and potassium checks1 | Women with androgen signs or progressing loss |
| Spironolactone plus oral minoxidil | In 432 women, side effects were reported by 37.7%, mostly mild9 | Facial hair and dizziness were most common9 | Women whose dermatologist recommends combining |
| Low-level laser cap | FDA-cleared; a sham-controlled trial in women found more growth with active treatment1011 | Upfront cost; must keep using1 | Women who want a drug-free option, alone or as an add-on |
Our sister site Shedding Point has month-by-month timelines for topical minoxidil, oral minoxidil, spironolactone and laser caps, so you know what to expect each month.
Topical minoxidil: the usual first step
Minoxidil lengthens the growth phase and enlarges shrinking follicles. The AAD notes a temporary increase in shedding in the first two to eight weeks, which is a sign it is working on the hair cycle, and that it takes six to twelve months to know how well it works; stopping loses the benefit1. The 5% strength caused more itching and irritation than 2% in the main trial, and some women notice unwanted facial hair5. Foam formulations can be gentler on sensitive scalps. You can buy it over the counter; we do not link a specific brand.
Prescription pills
Spironolactone blocks androgen effects and is a common choice when there are signs of androgen excess. Because it may cause birth defects, dermatologists recommend birth control for premenopausal women who take it1. Low-dose oral minoxidil is increasingly prescribed off-label. A safety study of 1,404 patients found systemic side effects uncommon7. Some dermatologists combine the two; a 2026 study of 432 women found side effects were mostly mild and managed without hospital care9. These are decisions to make with a dermatologist who can monitor you. For a full hair and scalp assessment, including a review of your blood work, you can also find a trichologist.
Laser caps: the drug-free option
Low-level laser therapy uses red light to stimulate follicles. The FDA has cleared laser cap devices for pattern hair loss10, and the AAD notes a few studies show they can be effective, and that continued use is needed1. In a randomised, sham-controlled trial in women, active treatment produced more hair growth than a sham device over 16 weeks11. A cap suits women who prefer to avoid medicines, cannot tolerate minoxidil, or want an add-on to it. It is not a treatment for scarring hair loss.
Supportive care
Some women want a gentle daily step alongside a proven treatment, or while they wait for a diagnosis. Botanical serums are one option; the evidence base is much smaller than for minoxidil, so treat a serum as a complement rather than a replacement. Add one new product at a time and judge it with monthly photos.
What does not belong on the list
- Iron or vitamin D without a confirmed deficiency. Evidence does not support them for women with normal levels, and both can cause harm in excess1213.
- High-dose biotin. It can distort thyroid tests14.
- HRT for hair alone. A 2026 review found HRT is not indicated for hair loss alone15.
Deciding together
Not sure where to start? The treatment match quiz asks four questions about your stage, diagnosis and preferences and suggests a starting point to discuss with your clinician.
Questions women ask
Which is better for women, oral or topical minoxidil?
How long before a hair loss treatment works?
Sources
- American Academy of Dermatology. Thinning hair and hair loss: could it be female pattern hair loss? Open source
- Carmina E, Azziz R, Bergfeld W, et al. Female pattern hair loss and androgen excess: a report from the Multidisciplinary Androgen Excess and PCOS Committee. J Clin Endocrinol Metab. 2019;104(7):2875-2891. Open source
- American Academy of Dermatology. Do you have hair loss or hair shedding? Open source
- American Academy of Dermatology. Central centrifugal cicatricial alopecia: overview. Open source
- Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541-553. Open source
- Ramos PM, Sinclair RD, Kasprzak M, Miot HA. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial. J Am Acad Dermatol. 2020;82(1):252-253. Open source
- Vano-Galvan S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. Open source
- Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466-473. Open source
- Dewey E, Salloum L, Gregoire S, et al. Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: a retrospective cohort study. J Am Acad Dermatol. 2026;94(6):1679-1685. Open source
- US FDA 510(k) database. K150613, "LaserCap LC Pro and LC Elite", Transdermal Cap, Inc., decision 22 July 2015 (product code OAP). Open source
- Lanzafame RJ, Blanche RR, Chiacchierini RP, et al. The growth of human scalp hair in females using visible red light laser and LED sources. Lasers Surg Med. 2014;46(8):601-607. Open source
- Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824-844. Open source
- NIH Office of Dietary Supplements. Vitamin D: fact sheet for health professionals. Open source
- British Thyroid Foundation. Hair loss and thyroid disorders. Open source
- Lee J, Krishnegowda R, Miteva MI. Hormone replacement therapy and hair: a review for trichologists treating menopausal women. Dermatology. 2026;242(3):264-267. Open source
- Advanced Trichology. HairStem Laser Cap product page (80 diodes, 650 nm, directions for use). Manufacturer information. Open source
Checked 17 November 2026. Read our editorial policy.